BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37253561)

  • 1. [Comparison of the disease burden of schistosomiasis globally and in China and Zimbabwe].
    Li H; Zheng J; Qian Y; Lü S; Xia S; Zhou X
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2023 May; 35(2):128-136. PubMed ID: 37253561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Temporal trends in disease burden of major human parasitic diseases in China from 1990 to 2019].
    Zeng T; Lü S; Tian L; Li S; Sun L; Jia T
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2023 Mar; 35(1):7-14. PubMed ID: 36974009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epidemiological trends for human schistosomiasis prevalence in Hubei Province from 2004 to 2018 based on Joinpoint regression analysis].
    Xiao Y; Zhong CH; Wei FH; Dai LF; Yang JJ; Chen YY
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2022 Apr; 34(2):122-127. PubMed ID: 35537833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in the disease burden of congenital heart disease in China over the past three decades.
    Pan F; Xu W; Li J; Huang Z; Shu Q
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 51(3):267-277. PubMed ID: 36207836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of the disease burden of pneumoconiosis globally and in China from 1990 to 2019].
    Chen X; Chen YF
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2023 Jun; 41(6):417-424. PubMed ID: 37400401
    [No Abstract]   [Full Text] [Related]  

  • 6. [Analysis and prediction of burden of viral hepatitis C-associated diseases in China from 1990 to 2044].
    Zhou M; Yao L; Wu Y; Lin S; Huang J
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2023 Dec; 35(5):476-485. PubMed ID: 38148536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Disease burden and prediction of oral cancer attributable to smoking in China from 1990 to 2019].
    Gu JC; Liu Y; Wang XL; Zhang LL; Liu YX
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2023 Sep; 58(9):919-925. PubMed ID: 37659850
    [No Abstract]   [Full Text] [Related]  

  • 8. [Burden of hepatitis B-associated diseases in China from 1990 to 2030].
    Yao L; Lin S; Huang J; Wu Y
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2023 Nov; 35(5):464-475. PubMed ID: 38148535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burden of stroke in China and the different SDI regions over the world.
    Mi Y; Huai L; Yin Y; Yuan J; Liu Y; Huang J; Li W
    J Glob Health; 2023 Dec; 13():04169. PubMed ID: 38131457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global, regional, and national burden of ischaemic heart disease and its trends, 1990-2019.
    Guan C; Wu S; Xu W; Zhang J
    Public Health; 2023 Oct; 223():57-66. PubMed ID: 37604031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease burden of COPD attributable to PM
    Cheng XF; Min SH; Guo RQ; Zhang JD; Zhang YL; Li B
    BMJ Open; 2024 Feb; 14(2):e078887. PubMed ID: 38355185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of Disease Burden Factors of Thyroid Cancer Between China and the World From 1990 to 2019].
    Su W; Xu YT; Wang YN; Wu YY; Wan W; Gao WQ; Gao Y; Shi YY; Ma S
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Dec; 45(6):940-948. PubMed ID: 38173105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence trend and burden of neglected parasitic diseases in China from 1990 to 2019: findings from global burden of disease study.
    Xie Y; Shi D; Wang X; Guan Y; Wu W; Wang Y
    Front Public Health; 2023; 11():1077723. PubMed ID: 37293619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [DALYs for breast cancer in China, 2000-2050: trend analysis and prediction based on GBD 2019].
    Yan XX; Li YJ; Cao MD; Wang H; Liu CC; Wang X; Ran JC; Liang L; Lei L; Peng J; Shi JF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Dec; 42(12):2156-2163. PubMed ID: 34954980
    [No Abstract]   [Full Text] [Related]  

  • 15. Disease burden of breast cancer and risk factors in Europe 44 countries, 1990-2019: findings of the global burden of disease study 2019.
    Yu S; Cai X; Wang X; Lin X; Cai S
    Front Endocrinol (Lausanne); 2024; 15():1405204. PubMed ID: 38846496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global, regional, national burden and gender disparity of cataract: findings from the global burden of disease study 2019.
    Fang R; Yu YF; Li EJ; Lv NX; Liu ZC; Zhou HG; Song XD
    BMC Public Health; 2022 Nov; 22(1):2068. PubMed ID: 36369026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term trends in the burden of inflammatory bowel disease in China over three decades: A joinpoint regression and age-period-cohort analysis based on GBD 2019.
    Zhang Y; Liu J; Han X; Jiang H; Zhang L; Hu J; Shi L; Li J
    Front Public Health; 2022; 10():994619. PubMed ID: 36159285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global burden and trends of the Entamoeba infection-associated diseases from 1990 to 2019: An observational trend study.
    Fu X; Zhong Y; Chen L; Ge M; Yu M; Sun Y; Shen L
    Acta Trop; 2023 Apr; 240():106866. PubMed ID: 36801451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Disease burden of colorectal cancer in China: any changes in recent years?].
    Wang H; Cao MD; Liu CC; Yan XX; Huang HY; Zhang Y; Chen HD; Ren JS; Li N; Chen WQ; Dai M; Shi JF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Oct; 41(10):1633-1642. PubMed ID: 33297619
    [No Abstract]   [Full Text] [Related]  

  • 20. Burden of chronic kidney disease and its risk-attributable burden in 137 low-and middle-income countries, 1990-2019: results from the global burden of disease study 2019.
    Ke C; Liang J; Liu M; Liu S; Wang C
    BMC Nephrol; 2022 Jan; 23(1):17. PubMed ID: 34986789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.